Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A collaborative effort between the Jenner Institute and the Kennedy Institute of Rheumatology with colleagues atthe University of Bern and the Latvian Biomedical Research & Study Centre, have developed and tested a vaccine that could be used to treat chronic pain caused by osteoarthritis, by blocking the cause of the pain.

This research brought together Professor Bachmann’s group developing therapeutic vaccines for non-communicable diseases, with Professor Vincent’s group at the Versus Arthritis Centre for Osteoarthritis Pathogenesis.

Read the full article

Similar stories

Oxford researchers join Novo, Gates, and Wellcome to tackle antimicrobial resistance

Oxford researchers from the Nuffield Department of Medicine are part of a major new international initiative with the Novo Nordisk Foundation, Wellcome and the Gates Foundation to accelerate the discovery of urgently needed antibiotics. The Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) brings together global expertise to tackle drug-resistant Gram-negative infections, one of the most serious threats to global health.